Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 154-158, Vol. 69, No. 1
Cellular Microbiology Research Group, Eastman
Dental Institute, University College London, London WC1X
8LD,1 and Division of Endocrinology,
National Institute for Biological Standards and Control, Potters
Bar, Herts,2 United Kingdom
Received 14 September 2000/Accepted 11 October 2000
Thioredoxin is a ubiquitous redox control and cell stress protein.
Unexpectedly, in recent years, thioredoxins have been found to exhibit
both cytokine and chemokine activities, and there is increasing
evidence that this class of protein plays a role in the pathogenesis of
inflammatory diseases. In spite of this evidence, it has been reported
that the oral bacterium and periodontopathogen Actinobacillus
actinomycetemcomitans secretes an immunosuppressive factor
(termed suppressive factor 1 [SF1] [T. Kurita-Ochiai and K. Ochiai,
Infect. Immun. 64:50-54, 1996]) whose N-terminal sequence, we have
determined, identifies it as thioredoxin. We have cloned and expressed
the gene encoding the thioredoxin of A. actinomycetemcomitans and have purified the protein to
homogeneity. The A. actinomycetemcomitans trx gene has 52 and 76% identities, respectively, to the trx genes of
Escherichia coli and Haemophilus influenzae.
Enzymatic analysis revealed that the recombinant protein had the
expected redox activity. When the recombinant thioredoxin was tested
for its capacity to inhibit the production of cytokines by human
peripheral blood mononuclear cells, it showed no significant inhibitory
capacity. We therefore conclude that the thioredoxin of A. actinomycetemcomitans does not act as an immunosuppressive
factor, at least with human leukocytes in cultures, and that the
identity of SF1 remains to be elucidated.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.154-158.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cloning and Expression of the Actinobacillus
actinomycetemcomitans Thioredoxin (trx) Gene and
Assessment of Cytokine Inhibitory Activity
*
Corresponding author. Mailing address: Cellular
Microbiology Research Group, Eastman Dental Institute,
University College London, 256 Gray's Inn Rd., London WC1X 8LD, United
Kingdom. Phone: 0171 915 1190. Fax: 0171 915 1190. E-mail:
b.henderson{at}eastman.ucl.ac.uk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»